Rosuvastatin Completed Phase 4 Trials for Diabetes Mellitus (DM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00658463Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients
NCT02185963Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes